These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 26371985)

  • 1. [Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].
    Kauss Hornecker M; Charles Weber S; Brandely Piat ML; Darrodes M; Jomaa K; Chast F
    J Fr Ophtalmol; 2015 Oct; 38(8):700-8. PubMed ID: 26371985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topical cyclosporine in ophthalmology: Pharmacology and clinical indications].
    Levy O; Labbé A; Borderie V; Laroche L; Bouheraoua N
    J Fr Ophtalmol; 2016 Mar; 39(3):292-307. PubMed ID: 26997607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.
    Westland T; Patryn EK; Nieuwendaal CP; van der Meulen IJE; Mourits MP; Lapid-Gortzak R
    Int Ophthalmol; 2018 Feb; 38(1):363-368. PubMed ID: 28120172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-European survey of the topical ocular use of cyclosporine A.
    Labbé A; Baudouin C; Ismail D; Amrane M; Garrigue JS; Leonardi A; Figueiredo FC; Van Setten G; Labetoulle M
    J Fr Ophtalmol; 2017 Mar; 40(3):187-195. PubMed ID: 28318723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study.
    Magalhaes OA; Marinho DR; Kwitko S
    Br J Ophthalmol; 2013 Nov; 97(11):1395-8. PubMed ID: 24008822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine nanomicelle eye drop: a novel medication for corneal graft transplantation treatment.
    Zhang H; Wang L; Zhang L
    Biol Pharm Bull; 2015; 38(6):893-900. PubMed ID: 26027830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
    Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
    Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops.
    Napoli PE; Braghiroli M; Iovino C; Demarinis G; Fossarello M
    Drug Des Devel Ther; 2019; 13():2001-2008. PubMed ID: 31354245
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prospective, monocentric, uncontrolled study of efficacy, tolerance and adherence of cyclosporin 0.1 % for severe dry eye syndrome].
    Boujnah Y; Mouchel R; El-Chehab H; Dot C; Burillon C; Kocaba V
    J Fr Ophtalmol; 2018 Feb; 41(2):129-135. PubMed ID: 29449025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative approach to topical cyclosporine therapy.
    Williams DL
    Eye (Lond); 1997; 11 ( Pt 4)():453-64. PubMed ID: 9425407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
    Kiliç A; Gürler B
    Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical review: topical ophthalmic use of cyclosporin A.
    Utine CA; Stern M; Akpek EK
    Ocul Immunol Inflamm; 2010 Oct; 18(5):352-61. PubMed ID: 20735287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical ophthalmic cyclosporine: pharmacology and clinical uses.
    Donnenfeld E; Pflugfelder SC
    Surv Ophthalmol; 2009; 54(3):321-38. PubMed ID: 19422961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
    Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
    Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.